deucravacitinib
bms
['lupus', 'deucra']
2022 has been a great year for development of novel therapies in phase 2 rcts in #lupus as highlighted by dr langford #acr22 year in review. i'd add deucravacitinib to those lists. look forward to phase 3 results soon 
Rheumatologist. Interested in B-cells, Lupus, Sjogren, Pre-Connective Tissue Disease, Tennis, Running & Travelling ??